Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-10-051463
Filing Date
2010-03-09
Accepted
2010-03-09 17:02:11
Documents
6
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM 10-K d10ka.htm 10-K/A 1141058
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1586
3 CERTIFICATION OF PEO REQUIRED UNDER RULES 13A-14(A) OR 15D-14(A) dex311.htm EX-31.1 9878
4 CERTIFICATION OF PFO REQUIRED UNDER RULES 13A-14(A) OR 15D-14(A) dex312.htm EX-31.2 9865
5 CERTIFICATION OF PEO AND PFO REQUIRED UNDER RULE 13A-14(B) dex321.htm EX-32.1 5991
6 GRAPHIC g37268g16j59.jpg GRAPHIC 52804
  Complete submission text file 0001193125-10-051463.txt   1242679
Mailing Address 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043
Business Address 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043 650-386-3100
MAP Pharmaceuticals, Inc. (Filer) CIK: 0001401923 (see all company filings)

EIN.: 200507047 | State of Incorp.: DE
Type: 10-K/A | Act: 34 | File No.: 001-33719 | Film No.: 10667788
SIC: 2834 Pharmaceutical Preparations